Zachary Silbersher is a patent attorney with lead-counsel experience in patent litigation, petitions for inter partes review, prosecution and licensing. Zachary is a Founding Partner of Kroub, Silbersher & Kolmykov, an intellectual property litigation firm, and Markman Advisors, a leading consultancy on patent issues for the investment community. Prior to co-founding KSK and Markman Advisors, he spent years as an Associate at Locke Lord and Torys. His areas of focus include strategic patent monetization, patent-portfolio valuation, consultation with buy-side and sell-side analysts on patent litigations within pharma and high-tech spaces. Zachary has been quoted regularly in the media on patent issues, including The Wall Street Journal, Reuters, Bloomberg, Vox/Recode, Nature Biotechnology and FiercePharma, among others.
Zachary has also been quoted regularly on BioWorld, Law360, Intellectual Asset Management (IAM), The Capital Forum, the Patent Investor, and Best Lawyers.
He frequently blogs on patent issues, particularly those related to pharma at markmanadvisors.com/blog.
Zachary's Bar Admissions include New York - USPTO Reg.# 62,090.
Zachary Silbersher's Accomplishments
IAM Strategy 300 – The World’s Leading IP Strategists, 2015–2021
J.D. Law, Fordham University School of Law
B.S. Physics, Columbia University
B.A. Philosophy, Tufts University
Zachary Silbersher Admitted to Practice
C.A. Federal Circuit
E.D. New York
S.D. New York
W.D. New York